OZEMPIC.01
Pour le traitement des patients atteints d’un diabète sucré de type 2 insuffisamment contrôlé en …
Additional information from the official database
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
dapagliflozinum
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
dapagliflozinum propylenglycolum monohydricum
|
- | Substance | WIZUS |
|
saxagliptinum
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
saxagliptini hydrochloridum
|
- | Substance | WIZUS |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
lactosum
|
40.0 MG | Substance | HBESI |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
poly(alcohol vinylicus)
|
- | Substance | HNIDK |
|
macrogolum 3350
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
E 172 (rubrum)
|
- | Substance | FTODK |
|
E 132
|
- | Substance | FIMDK |
|
lacca
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
6340 Baar